Bloomberg Market Wrap 9/9: Russell 2000 DMA, Health-Care Stocks

The video discusses the performance of the Russell 2000 index, highlighting its recent outperformance in the energy sector and its position relative to the 200-day moving average. It also covers technical indicators like RSI and the implications of a downward-sloping moving average. Additionally, the video addresses the impact of potential drug pricing reforms on healthcare stocks, with a focus on Merck and upcoming legislative changes.

What does the Russell 2000's performance indicate about the market's near-term outlook?

What does the RSI indicator signify when it goes above 70 or below 30?

How does the 200-day moving average relate to the behavior of buyers and sellers in the market?

What potential challenges are healthcare stocks facing according to the text?

What actions are drugmakers expected to take when Congress returns, based on the information provided?